acrolein has been researched along with Alloxan Diabetes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Çelik, R; Comba, B; Mert, H; Mert, N | 1 |
| Liu, S; Wan, J; Wang, D; Wang, P; Yang, Q; Yang, Y; Zhou, P | 1 |
| Amiya, E | 1 |
| Duan, M; Liu, R; Wang, L; Wu, H; Zhang, K; Zhao, H; Zhu, Q | 1 |
| Henriquez, A; Kodavanti, UP; Ledbetter, AD; McGee, MA; Richards, JE; Schladweiler, MC; Snow, SJ | 1 |
| Lee, SC; Lin, LY; Liu, CT; Xu, WX; Yang, JJ | 1 |
| Chen, X; Huang, J; Li, J; Li, M; Li, X; Liang, X; Luo, Y; Ma, W; Tang, S; Xiao, W | 1 |
| Chishti, S; Hafizur, RM; Hameed, A; Kabir, N; Raza, SA; Shukrana, M; Siddiqui, RA | 1 |
| Bishnoi, M; Datusalia, AK; Jawale, A; Sharma, SS | 1 |
| Anand, P; Chandra, R; Murali, KY; Murthy, PS; Tandon, V | 1 |
| Baba, SP; Bhatnagar, A; Hellmann, J; Srivastava, S | 1 |
| Badawy, D; El-Bassossy, HM; Fahmy, A | 1 |
| Kumar, S; Sharma, S; Vasudeva, N | 1 |
| Ignacimuthu, S; Prabuseenivasan, S; Subash Babu, P | 1 |
14 other study(ies) available for acrolein and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of cinnamaldehyde on glucose-6-phosphate dehydrogenase activity, some biochemical and hematological parameters in diabetic rats.
Topics: Acrolein; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Glucosephosphate Dehydrogenase; Humans; Liver; Rats; Rats, Wistar | 2022 |
Cinnamaldehyde Ameliorates Vascular Dysfunction in Diabetic Mice by Activating Nrf2.
Topics: Acrolein; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Evaluation, Preclinical; Flavoring Agents; Kidney; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; TRPA1 Cation Channel | 2020 |
Nrf-2: The Target of Vascular Dysfunction in Diabetes.
Topics: Acrolein; Animals; Diabetes Mellitus, Experimental; Mice; NF-E2-Related Factor 2; Signal Transduction | 2020 |
Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota.
Topics: Acrolein; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Streptozocin | 2021 |
Respiratory Effects and Systemic Stress Response Following Acute Acrolein Inhalation in Rats.
Topics: Acrolein; Animals; Cholesterol; Corticosterone; Diabetes Mellitus, Experimental; Epinephrine; Fatty Acids, Nonesterified; Glucose Intolerance; Hyperglycemia; Inhalation Exposure; Male; Rats; Rats, Wistar; Respiratory System; Stress, Physiological | 2017 |
Chemical composition and hypoglycemic and pancreas-protective effect of leaf essential oil from indigenous cinnamon (Cinnamomum osmophloeum Kanehira).
Topics: Acrolein; Acyclic Monoterpenes; Animals; Blood Glucose; Cinnamomum; Diabetes Mellitus, Experimental; Fasting; Fructosamine; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Monoterpenes; Oils, Volatile; Oxidative Stress; Plant Leaves; Rats; Rats, Wistar; Volatile Organic Compounds | 2013 |
Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acrolein; Animals; Antioxidants; Blood Glucose; Blood-Retinal Barrier; Body Weight; Capillaries; Claudin-5; Deoxyguanosine; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Male; Mitochondria; Occludin; Oligopeptides; Oxidative Stress; Protective Agents; Protein Transport; Rats; Rats, Sprague-Dawley; Retina; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.
Topics: Acrolein; Animals; Blood Glucose; Cells, Cultured; Cinnamates; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice, Inbred BALB C; Rats, Wistar | 2015 |
Reversal of diabetes-induced behavioral and neurochemical deficits by cinnamaldehyde.
Topics: Acetylcholinesterase; Acrolein; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Cerebral Cortex; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Diet, High-Fat; Hippocampus; Interleukin-6; Male; Maze Learning; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |
Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats.
Topics: Acrolein; Animals; Body Weight; Cinnamomum zeylanicum; Diabetes Mellitus, Experimental; Drinking; Glucose Transporter Type 4; Glycogen; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Kidney; Lethal Dose 50; Liver; Male; Organ Size; Phosphoenolpyruvate Carboxykinase (ATP); Phosphoenolpyruvate Carboxykinase (GTP); Pyruvate Kinase; Rats; Rats, Wistar | 2010 |
Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).
Topics: Acrolein; Adipose Tissue; Aldehyde Reductase; Aldehydes; Animals; Diabetes Mellitus, Experimental; Dietary Fats; Epididymis; Gene Deletion; Gene Expression Regulation; Glycation End Products, Advanced; Kidney; Male; Mice; Obesity; Oxidation-Reduction; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2011 |
Cinnamaldehyde protects from the hypertension associated with diabetes.
Topics: Acetylcholinesterase; Acrolein; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium; Diabetes Mellitus, Experimental; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Nitric Oxide; Pioglitazone; Potassium Chloride; Rats; Rats, Wistar; Thiazolidinediones; Vasoconstriction | 2011 |
GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats.
Topics: Acrolein; Administration, Oral; Animals; Antioxidants; Biomarkers; Blood Glucose; Cinnamomum; Diabetes Mellitus, Experimental; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Glutathione; Glycated Hemoglobin; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipids; Liver; Male; Malondialdehyde; Oils, Volatile; Plant Leaves; Plant Oils; Rats; Rats, Wistar; Time Factors | 2012 |
Cinnamaldehyde--a potential antidiabetic agent.
Topics: Acrolein; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Cholesterol, HDL; Cinnamomum zeylanicum; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glycated Hemoglobin; Glycogen; Hypoglycemic Agents; Insulin; L-Lactate Dehydrogenase; Male; Phytotherapy; Plant Bark; Plant Extracts; Rats; Rats, Wistar; Streptozocin; Triglycerides | 2007 |